As digital health technologies expand across the UK, organizations face an important decision. Should they work with a specialist clinical safety or a generalist health tech consultancy? At early stages, both may seem equally capable. However, when a product begins to affect patient care, NHS workflows, or regulatory compliance, this choice becomes difficult. Selecting the wrong partner can lead to delays or safety issues. A specialist consultancy such as BMS Digital Safety focuses on ensuring that digital health solutions are safe and ready for NHS use making them essential in regulated environments.
Specialist vs Generalist: What’s the Difference?
A specialist clinical safety consultancy focuses specifically on managing clinical risk in digital health systems. Their role is to ensure that software is safe, compliant, and suitable for healthcare use.They work with UK standards such as DCB0129 and DCB0160, producing key documentation like a clinical safety case, hazard log and a clinical risk management plan.
A generalist health tech consultancy offers broader services such as product design, software development, and user experience. They are highly useful during early phases like ideation and product development, where the focus is on functionality rather than clinical safety. They may be able to advise on safety features, but lack the regulatory qualifications and experience to ensure compliance.
When Does Specialism Matter?
Specialist expertise becomes essential when a product moves into regulated or high-risk areas. This includes situations where your solution:
-
- Influences diagnosis or treatment decisions.
-
- Handles clinical data in meaningful ways.
-
- Qualifies as Software as a Medical Device.
-
- Requires evidence for NHS procurement.
-
- Integrates with NHS systems or workflows.
In these cases, organisations must comply with regulations such as the UK MDR 2002 and guidance from the Medicines and Healthcare products Regulatory Agency (MHRA).
Choose a specialist clinical safety partner when a product influences diagnosis or treatment decisions, integrates with NHS workflows, or is preparing for NHS procurement.
When a Generalist Consultancy Is Enough
Generalist consultancies are suitable when you are still exploring ideas or building prototypes, Clinical safety risks are minimal or not defined, The product does not directly impact patient outcomes and you need support with design, development, or scaling. At this stage, investing in specialist clinical safety services may not yet be necessary. Generalists can help create a strong product foundation before introducing compliance focused expertise later.
UK Frameworks that Shape the Decision
In UK, several frameworks guide how digital health technologies are developed and assessed. These frameworks often determine whether specialist input is required.
Key frameworks include:
-
- DCB0129: Clinical risk management for manufacturers.
-
- DCB0160: Clinical risk management for healthcare organisations.
-
- DTAC (Digital Technology Assessment Criteria): Used in NHS procurement.
-
- Software as a Medical Device: Classification for medical software.
-
- UK MDR 2002: Legal framework for medical devices.
-
- NICE Evidence Standards Framework: Defines required levels of clinical evidence.
UK decisions should consider DCB0129, DCB0160, DTAC, MHRA guidance for software as a medical device, and the NICE Evidence Standards Framework.
Evidence Quality Over Activity
When choosing a consultancy, it is important to focus on outcomes rather than activity. A high number of meetings or workshops does not guarantee compliance or safety.
Instead, organizations should evaluate the clarity of the clinical safety case, the completeness of the hazard log, audit-ready documentation and defined release and sign-off processes.
Evaluate providers on the clarity and audit readiness of safety cases, hazard logs, and release sign off trails, not on the number of workshops delivered.
Ownership of Clinical Risk
A critical but often overlooked factor is the ownership of clinical risk. This must be clearly defined at the beginning of the project.
Organizations should agree on “Who is responsible for clinical risk decisions? Who signs off product releases? How safety issues are identified and escalated? How risks are managed after launch?”
Agree who owns clinical risk decisions and post market surveillance before signing a contract, including how quickly safety issues will be triaged.
The Role of BMS Digital Safety
Organizations operating in regulated health environments often require expert support to meet UK compliance standards. BMS Digital Safety provides specialist clinical safety consultancy, helping teams align with frameworks such as UK MDR, DCB0129, DCB0160, and DTAC while producing audit-ready documentation. Their expertise ensures that digital health solutions are not only functional but also safe, and ready for NHS deployment.
Key Takeaways
-
- Choose a specialist consultancy when your product affects patient safety or NHS workflows.
-
- Use generalist consultancies during early development stages.
-
- Align with UK frameworks such as DCB0129, DCB0160, and DTAC.
-
- Focus on documentation quality rather than activity.
-
- Clearly define ownership of clinical risk.
In UK digital health, the choice between specialist and generalist consultancies depends on the level of clinical risk and regulatory exposure. While generalists are valuable in early stages, specialist expertise becomes essential as soon as products interact with patient care or require compliance with UK standards. If your organization is developing a solution that impacts patient safety or NHS systems, working with a trusted partner like BMS Digital Safety can help ensure compliance, reduce risk, and support long term success.